Providing an in vivo model for MPLW515L-positive myeloproliferative neoplasms (MPNs)
doi.org/10.1172/JCI1...
Baobing Zhao & team report a megakaryocyte HSC subpopulation as the disease-initiating compartment, driving essential thrombocythemia‑like MPN that resists JAK inhibitor therapy
